Assessment of Response to the Conventional Periodontal Treatment Based on the Blood Group Phenotypes.
Investigating the Role of ABO Blood Group in the Response to the Nonsurgical Periodontal Treatment.
1 other identifier
observational
60
1 country
1
Brief Summary
The aim of this study is to find out if one blood group phenotype is more responsive than the others to the nonsurgical periodontal treatment.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jan 2018
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 15, 2018
CompletedFirst Submitted
Initial submission to the registry
August 2, 2018
CompletedFirst Posted
Study publicly available on registry
August 23, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
March 10, 2019
CompletedMarch 13, 2019
March 1, 2019
9 months
August 2, 2018
March 12, 2019
Conditions
Outcome Measures
Primary Outcomes (1)
Change in relative attachment level.
the relative attachment level measures the length form the base of the periodontal pocket to a stent
measures will be taken at baseline and after two months from treatment.
Secondary Outcomes (3)
Change in periodontal probing depth.
measures will be taken at baseline and after two months from treatment.
Change in gingival index
index will be taken at baseline and after two months from treatment.
Change in plaque Index
index will be taken at baseline and after two months from treatment.
Study Arms (4)
Patients whose blood type is A
Applying nonsurgical periodontal treatment (scaling and root planning).
Patients whose blood type is B
Applying nonsurgical periodontal treatment (scaling and root planning).
Patients whose blood type is AB
Applying nonsurgical periodontal treatment (scaling and root planning).
Patients whose blood type is O
Applying nonsurgical periodontal treatment (scaling and root planning).
Interventions
patients will undergo nonsurgical periodontal treatment to reduce the relative attachment level and improve the probing depth. An initial session will be conducted to remove supra gingival plaque and calculus. another appointment is set to perform full moth scalling and root planing.
Eligibility Criteria
Patients suffering from chronic periodontitis
You may qualify if:
- systematically healthy.
- have at least 20 teeth excluding the third molars.
- had not received any periodontal treatment or antibiotic therapy for dental or medical reason 6 month prior to the study.
- diagnosed with generalized chronic periodontitis (\>30% of the sites have probing depth ≥4), and a minimum of six teeth with probing depth of 5-6 mm.
You may not qualify if:
- smokers and alcoholics.
- pregnancy.
- history of a systematic disease such as diabetes, leukemia, epilepsy.
- participants who are unable to perform routine oral hygiene.
- use of orthodontic appliances.
- participants who are unable to perform routine oral hygiene.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Department of Periodontics
Damascus, DM20AM18, Syria
Related Publications (5)
Pai GP, Dayakar MM, Shaila M, Dayakar A. Correlation between "ABO" blood group phenotypes and periodontal disease: Prevalence in south Kanara district, Karnataka state, India. J Indian Soc Periodontol. 2012 Oct;16(4):519-23. doi: 10.4103/0972-124X.106892.
PMID: 23493096BACKGROUNDDemir T, Tezel A, Orbak R, Eltas A, Kara C, Kavrut F. The Effect of ABO Blood Types on Periodontal Status. Eur J Dent. 2007 Jul;1(3):139-43.
PMID: 19212557BACKGROUNDGautam A, Mittal N, Singh TB, Srivastava R, Verma PK. Correlation of ABO Blood Group Phenotype and Rhesus Factor with Periodontal Disease: An Observational Study. Contemp Clin Dent. 2017 Apr-Jun;8(2):253-258. doi: 10.4103/ccd.ccd_307_17.
PMID: 28839412BACKGROUNDWang W, Liu L, Wang Z, Wei M, He Q, Ling T, Cao Z, Zhang Y, Wang Q, Shi M. Impact of ABO blood group on the prognosis of patients undergoing surgery for esophageal cancer. BMC Surg. 2015 Sep 29;15:106. doi: 10.1186/s12893-015-0094-1.
PMID: 26420728BACKGROUNDYu Q, Wang L, Zhang S, Feng T, Li L, Chen B, Chen M. The role of ABO blood groups in Crohn's disease and in monitoring response to infliximab treatment. Blood Transfus. 2016 Sep;14(5):460-4. doi: 10.2450/2016.0199-15. Epub 2016 Feb 24.
PMID: 27136434BACKGROUND
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Mohammad Ammar Kouky, DDS MSc
PhD Student in Periododontics, University of Damascus Dental School, Damascus
- STUDY CHAIR
Mohammad Monzer Alsabbagh, DDS MSc PhD
Associate Professor of Periodontics, University of Damascus Dental School, Damascus, Syria
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 2, 2018
First Posted
August 23, 2018
Study Start
January 15, 2018
Primary Completion
October 1, 2018
Study Completion
March 10, 2019
Last Updated
March 13, 2019
Record last verified: 2019-03
Data Sharing
- IPD Sharing
- Will not share